1 week Ago By ABMN Staff
Pulse Biosciences ( NASDAQ:PLSE – Get Free Report ) was upgraded by equities researchers at StockNews.com to a “sell” rating in a report released on Thursday. Pulse Biosciences Stock Performance PLSE stock opened at $17.
41 on Thursday. Pulse Biosciences has a twelve month low of $6.59 and a twelve month high of $22.
69. The business has a 50 day moving average price of $18.03 and a two-hundred day moving average price of $16.
89. Pulse Biosciences ( NASDAQ:PLSE – Get Free Report ) last released its earnings results on Wednesday, October 30th. The company reported ($0.
21) earnings per share for the quarter. During the same quarter last year, the company earned ($0.19) EPS.
Insider Activity Institutional Trading of Pulse Biosciences Several hedge funds have recently added to or reduced their stakes in PLSE. Quest Partners LLC acquired a new position in Pulse Biosciences in the 2nd quarter valued at $91,000. Creative Planning boosted its position in shares of Pulse Biosciences by 113.
9% in the third quarter. Creative Planning now owns 21,910 shares of the company’s stock valued at $384,000 after acquiring an additional 11,667 shares during the period. Franklin Resources Inc.
acquired a new position in shares of Pulse Biosciences in the third quarter valued at about $378,000. Rhumbline Advisers increased its position in Pulse Biosciences by 6.7% during the second quarter.
Rhumbline Advisers now owns 25,729 shares of the company’s stock worth $288,000 after acquiring an additional 1,608 shares during the period. Finally, Barclays PLC increased its position in Pulse Biosciences by 361.4% during the third quarter.
Barclays PLC now owns 30,306 shares of the company’s stock worth $530,000 after acquiring an additional 23,738 shares during the period. 76.95% of the stock is owned by institutional investors and hedge funds.
About Pulse Biosciences ( Get Free Report ) Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. See Also Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.
com's FREE daily email newsletter ..
